Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Diluted Average) (2018 - 2025)

Fortress Biotech has reported Shares Outstanding (Diluted Average) over the past 8 years, most recently at $27.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $27.9 million for Q4 2025, up 34.24% from a year ago — trailing twelve months through Dec 2025 was $27.9 million (up 34.24% YoY), and the annual figure for FY2025 was $27.9 million, up 34.24%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $27.9 million at Fortress Biotech, down from $29.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for FBIO hit a ceiling of $101.9 million in Q1 2023 and a floor of $5.9 million in Q3 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $26.5 million (2025), compared with a mean of $41.8 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 92.76% in 2022 and later soared 172.4% in 2024.
  • Fortress Biotech's Shares Outstanding (Diluted Average) stood at $81.7 million in 2021, then crashed by 92.75% to $5.9 million in 2022, then soared by 36.89% to $8.1 million in 2023, then skyrocketed by 156.25% to $20.8 million in 2024, then skyrocketed by 34.24% to $27.9 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $27.9 million (Q4 2025), $29.2 million (Q2 2025), and $26.5 million (Q1 2025) per Business Quant data.